Email updates

Keep up to date with the latest news and content from BMC Cardiovascular Disorders and BioMed Central.

Open Access Research article

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease

Tricia Nicholson1*, Alistair McGuire2 and Ruairidh Milne1

Author Affiliations

1 Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK

2 Economics Department, City University, London, UK

For all author emails, please log on.

BMC Cardiovascular Disorders 2001, 1:2  doi:10.1186/1471-2261-1-2

Published: 15 October 2001

Additional files

Additional material 1: Section A: Information about systematic review methods:

This gives fuller explanation to allow readers to assess the adequacy of the methods used to obtain data for the cost-utility model.

Format: DOC Size: 102KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional material 2: Section B: Additional information about health economics methods:

This additional information complies with the Drummond et al (1996) guidelines for reporting health economic papers http://www.bmj.com/cgi/content/full/313/7052/275 webcite. Furthermore, this section allows readers to test the effect of substituting their own variables.

Format: DOC Size: 245KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional material 3: Section C: Data extraction tables for clinical trials:

These have been added for completeness as they give full details (including comments about their quality) of the trials used for the effectiveness estimates.

Format: DOC Size: 126KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data